A polyimide precursor solution, includes: a polyimide precursor; resin particles having a volume average particle diameter of 5 nm or more and 100 nm or less, and having a volume particle size distribution wherein a ratio of a volume frequency of resin particles having a particle diameter of 150 nm or more to a volume frequency of all of the resin particles in the polyimide precursor solution is 5% or less; and an aqueous solvent containing water.

A polyimide precursor solution contains a polyimide precursor, resin particles having a core and a coating resin layer, the coating resin layer contains a melamine resin, and a solvent.

A particle-dispersed polyimide precursor solution contains: a polyimide precursor consisting of a polymer of a tetracarboxylic dianhydride and a diamine containing a fluorene-based diamine having a fluorene skeleton; particles; and an aqueous solvent containing water.

The present disclosure relates to a process for the processing of perfluoropolymer materials, and to the use of the resultant products in different potential applications, such as in the medical device field. The process can include, for example, the steps of: (i) dissolving one or more uncured perfluoropolymer materials in a solvent containing one or more liquid perfluorinated solvent(s) to form a solution; (ii) optionally adding one or more porogens and/or one or more functional additives to the solution formed in (i) to form a mixture; (iii) applying the resultant solution or mixture formed in steps (i) and (ii) to a substrate to form one or more partial or continuous deposited layers on the substrate; (iv) curing the perfluoropolymer within the deposited layer to form a perfluoroelastomeric product; and (v) optionally removing the porogen from the perfluoroelastomeric product.

Methods of making polytetrafluoroethylene (PTFE)/polymer composites are disclosed herein. The products can be used in the field of bio- and medical applications, such as for use in artificial blood vessels, vascular grafts, cardiovascular and soft tissue patches, facial implants, surgical sutures, and endovascular prosthesis, and for any products known in the aerospace, electronics, fabrics, filtration, industrial and sealant arts.

A polyimide precursor-containing aqueous composition contains at least one polymer material selected from the group consisting of a water-insoluble fibrous organic substance and a polyalkylene oxide having a viscosity-average molecular weight of 5 million or more, a polyimide precursor, particles, and water.

A method of manufacturing a flexible intrinsically antimicrobial absorbent porosic composite controlling for an effective pore size using removable pore-forming substances and physically incorporated, non-leaching antimicrobials. A flexible intrinsically antimicrobial absorbent porosic composite controlled for an effective pore size composited physically incorporated, high-surface area, non-leaching antimicrobials, optionally in which the physically incorporated non-leaching antimicrobial exposes nanopillars on its surface to enhance antimicrobial activity. A kit that enhances the effectiveness of the intrinsically antimicrobial absorbent porosic composite by storing the composite within an antimicrobial container.

Loadable porous structures are disclosed, which are structures with pre-formed pores. The loadable porous structures can be loaded with pharmaceutical substances and optional excipients. The loaded porous structures can then be used as implants, for implantation into a patient for release of pharmaceutical substances over long periods of time. Methods of making and using such structures and implants are also disclosed.

A porous polyimide film has an acid value within a range of 7 mgKOH/g to 20 mgKOH/g determined by acid-base titration, contains a metal group including alkali metals excluding Li, an alkaline earth metals, and silicon at a total content of 100 ppm or less relative to the porous polyimide film, and has a moisture absorption ratio of 0.5% or less.

A porous, polymer aerogel having a pore size distribution with a full-width at half maximum between 0.1 and 10 nanometers, a visible transmittance greater than 30%/3 mm, haze less than 70%/3 mm, and a color rendering index of at least 25. A method of forming a porous, polymer aerogel, includes producing a miscible formulation of at least one of monomers, oligomers, crosslinkers and prepolymers, polymerizing the miscible formulation to form a multiphasic gel, wherein phases are continuous and the multiphasic gel has at least one depolymerizable domain and at least one non-depolymerizable domain, and the at least one depolymerizable domain is chemically bonded to the at least one non-depolymerizable domain, and removing the depolymerizable domain or domains from the multiphasic gel to produce a porous aerogel with a color rendering index of at least 25. A method of forming a porous, polymer aerogel, including producing a miscible formulation of at least one monomer, oligomer or crosslinker, and a prepolymer having at least one reactive functional group, polymerizing the miscible formulation to form a multiphasic gel, wherein the prepolymer having at least one reactive functional group is chemically bonded to a polymer that results from the polymerization of the at least one monomer or oligomer, and phases are continuous and the multiphasic gel has at least one depolymerizable domain bonded to at least one non-depolymerizable domain, and placing the multiphasic gel in a depolymerization solution having a depolymerization solvent to chemically degrade the depolymerizable domain into smaller oligomers and monomers, removing the depolymerization solvent to produce a porous aerogel with a color rendering index of at least 25.